false
Catalog
Basics of Bup Prescribing - Dr. Sarah Spencer - 01 ...
Basics of Bup Prescribing - Dr. Sarah Spencer
Basics of Bup Prescribing - Dr. Sarah Spencer
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The transcript discusses how to prescribe buprenorphine for patients with limited or no previous experience with the medication. It emphasizes that buprenorphine is a safe and effective treatment for opioid use disorder and that all providers should feel comfortable prescribing it. The transcript also describes the different formulations of buprenorphine, including sublingual films and tablets, as well as long-acting injectables. It explains that the inclusion of naloxone in most buprenorphine formulations is only for abuse deterrent purposes and does not affect the medication's efficacy. The transcript highlights the importance of proper dosing and administration of buprenorphine, as well as monitoring for side effects and managing common symptoms such as nausea and constipation. It discusses the use of buprenorphine in various healthcare settings, including emergency rooms, primary care settings, and palliative care. The transcript addresses the issue of precipitated withdrawal when starting buprenorphine and provides strategies for avoiding and managing it. It emphasizes the need to individualize treatment plans and consider the unique needs and circumstances of each patient. The transcript also touches on the role of long-acting injectable buprenorphine in simplifying medication management and reducing the risk of relapse. It provides guidance on monitoring patients, tapering off buprenorphine, and fostering long-term recovery. Overall, the transcript aims to educate providers on the safe and effective prescribing of buprenorphine and to challenge common misconceptions and stigmas associated with the medication.
Keywords
buprenorphine
prescribing
safe and effective
opioid use disorder
formulations
naloxone
dosing
side effects
healthcare settings
long-acting injectable
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English